Quantify the severity of menopausal transitions.
Real-time clinical computation active
Enter biometric metrics to generate report
This assessment provides statistical probability and mathematical interpretation based on validated clinical equations. It is not a diagnostic tool.
Based on the Kupperman Index, this tool helps women quantify the severity of common menopausal symptoms. Tracking these values provides a clinical baseline for discussing hormone replacement therapy (HRT) or lifestyle adjustments with a healthcare provider.
The Kupperman Index was first published in 1953 by Dr. Herbert Kupperman. It remains one of the most cited tools in women's health for measuring the impact of estrogen decline.
Keep a journal for 7 days before taking this test. We often normalize symptoms that are actually quite severe when viewed in aggregate.